Millennium Management’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,000
Closed -$541K 6200
2025
Q1
$541K Sell
3,000
-12,200
-80% -$2.05M ﹤0.01% 4758
2024
Q4
$2.38M Sell
15,200
-20,600
-58% -$3.65M ﹤0.01% 3482
2024
Q3
$6.52M Buy
35,800
+27,200
+316% +$5.24M 0.01% 2608
2024
Q2
$1.58M Buy
8,600
+3,400
+65% +$571K ﹤0.01% 3738
2024
Q1
$925K Buy
+5,200
New +$722K ﹤0.01% 4361
2023
Q4
Sell
-10,000
Closed -$1.16M 6402
2023
Q3
$1.16M Buy
10,000
+4,900
+96% +$598K ﹤0.01% 4075
2023
Q2
$599K Buy
+5,100
New +$521K ﹤0.01% 4411
2022
Q4
Sell
-10,000
Closed -$697K 6870
2022
Q3
$697K Sell
10,000
-41,000
-80% -$2.96M ﹤0.01% 4661
2022
Q2
$3.35M Buy
51,000
+41,000
+410% +$2.55M ﹤0.01% 3197
2022
Q1
$665K Buy
+10,000
New +$624K ﹤0.01% 4892
2021
Q3
Sell
-3,200
Closed -$218K 7082
2021
Q2
$218K Sell
3,200
-25,400
-89% -$1.77M ﹤0.01% 5963
2021
Q1
$2.2M Buy
28,600
+15,800
+123% +$1.15M ﹤0.01% 3439
2020
Q4
$768K Buy
12,800
+2,800
+28% +$140K ﹤0.01% 3901
2020
Q3
$431 Buy
+10,000
New +$434K ﹤0.01% 3654

Other funds holding KRYS